Luis Sánchez del Campo Ferrer

Montenegro MF, Marti-Diaz R, Navarro A, Tolivia J, Sanchez-Del-Campo L, Cabezas-Herrera J, Rodriguez-Lopez JN. Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy. Cell Death Dis. 2023 Nov 23;14(11):761. doi: 10.1038/s41419-023-06288-9. PubMed PMID: 37996408; PubMed Central PMCID: PMC10667277.

AÑO: 2023; IF: 9.0

37996408

Bastonini E, Kovacs D, Lotti F, Sanchez-Del-Campo L. Editorial: Cell stress responses and metabolic reprogramming in skin diseases. Front Cell Dev Biol. 2023 Mar 1;11:1171812. doi: 10.3389/fcell.2023.1171812. eCollection 2023. No abstract available. PubMed PMID: 36936680; PubMed Central PMCID: PMC10014911.

AÑO: 2023; IF: 5.5

36936680

Sánchez-Del-Campo L, Martí-Díaz R, Montenegro MF, González-Guerrero R, Hernández-Caselles T, Martínez-Barba E, Piñero-Madrona A, Cabezas-Herrera J, Goding CR, Rodríguez-López JN. MITF induces escape from innate immunity in melanoma. J Exp Clin Cancer Res. 2021 Mar 31;40(1):117. doi: 10.1186/s13046-021-01916-8. PubMed PMID: 33789714; PubMed Central PMCID: PMC8015040.

AÑO: 2021; IF: 12.658

33789714

Hamm M, Sohier P, Petit V, Raymond JH, Delmas V, Le Coz M, Gesbert F, Kenny C, Aktary Z, Pouteaux M, Rambow F, Sarasin A, Charoenchon N, Bellacosa A, Sanchez-Del-Campo L, Mosteo L, Lauss M, Meijer D, Steingrimsson E, Jonsson GB, Cornell RA, Davidson I, Goding CR, Larue L. BRN2 is a non-canonical melanoma tumor-suppressor. Nat Commun. 2021 Jun 17;12(1):3707. doi: 10.1038/s41467-021-23973-5. PubMed PMID: 34140478; PubMed Central PMCID: PMC8211827.

AÑO: 2021; IF: 16.6

34140478

Montenegro MF, González-Guerrero R, Sánchez-Del-Campo L, Piñero-Madrona A, Cabezas-Herrera J, Rodríguez-López JN. PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation. Sci Rep. 2020 Aug 6;10(1):13275. doi: 10.1038/s41598-020-70289-3. PubMed PMID: 32764667; PubMed Central PMCID: PMC7413540.

AÑO: 2020; IF: 4.379

32764667